Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:59 PM
Ignite Modification Date:
2025-12-24 @ 1:59 PM
NCT ID:
NCT00026195
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed non-hematologic malignancy
* Brain metastases or primary brain tumors are eligible provided patient is not receiving steroids or antiepileptic medications
PATIENT CHARACTERISTICS:
Age:
* 18 to 55 or 70 and over
Performance status:
* CTC 0-2
Life expectancy:
* Not specified
Hematopoietic:
* Granulocyte count at least 1,500/mm\^3
* Platelet count at least 100,000/mm\^3
Hepatic:
* Bilirubin no greater than upper limit of normal (ULN)
* SGOT no greater than ULN
Renal:
* Creatinine no greater than ULN
Other:
* Not pregnant or nursing
* Fertile patients must use effective contraception
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* At least 4 weeks since prior chemotherapy (6 weeks for nitrosourea)
* No more than 1 prior chemotherapy regimen for metastatic disease (no limit if administered in the adjuvant setting)
* No prior camptothecin
Endocrine therapy:
* See Disease Characteristics
Radiotherapy:
* At least 4 weeks since prior radiotherapy
* No concurrent radiotherapy, including for palliation
Surgery:
* At least 4 weeks since prior major surgery
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00026195
Study Brief:
Protocol Section:
NCT00026195